Enhanced PPE Associated With Low Rates of SARS-CoV-2 Transmission During Tracheostomy

Approximately 5 percent to 15 percent of patients with COVID-19 require invasive mechanical ventilation (IMV) and, at times, tracheostomy. Details regarding the safety and use of tracheostomy in treating COVID-19 continue to evolve. Staibano, et al. (2021) sought to evaluate the association of tracheostomy with COVID-19 patient outcomes and the risk of SARS-CoV-2 transmission among healthcare professionals (HCPs).

English-language studies investigating patients with COVID-19 who were receiving IMV and undergoing tracheostomy. Observational and randomized clinical trials were eligible (no randomized clinical trials were found in the search).

Of the 156 studies that underwent full-text review, only 69 were included in the qualitative synthesis, and 14 of these 69 studies (20.3%) were included in the meta-analysis. A total of 4669 patients were included in the 69 studies, and the mean (range) patient age across studies was 60.7 (49.1-68.8) years (43 studies [62.3%] with 1856 patients). The researchers found that in all studies, 1854 patients (73.8%) were men and 658 (26.2%) were women. We found that 28 studies (40.6%) investigated either surgical tracheostomy or percutaneous dilatational tracheostomy. Overall, 3 of 58 studies (5.17%) identified a small subset of HCPs who developed COVID-19 that was associated with tracheostomy. Studies did not consistently report the number of HCPs involved in tracheostomy. Among the patients, early tracheostomy was associated with faster ICU discharge (mean difference, 6.17 days; 95% CI, −11.30 to −1.30), but no change in IMV weaning (mean difference, −2.99 days; 95% CI, −8.32 to 2.33) or decannulation (mean difference, −3.12 days; 95% CI, −7.35 to 1.12). There was no association between mortality or perioperative complications and type of tracheostomy. A risk-of-bias evaluation that used ROBINS-I demonstrated notable bias in the confounder and patient selection domains because of a lack of randomization and cohort matching. There was notable heterogeneity in study reporting.

The findings of this systematic review and meta-analysis indicate that enhanced personal protective equipment is associated with low rates of SARS-CoV-2 transmission during tracheostomy. Early tracheostomy in patients with COVID-19 may reduce ICU stay, but this finding is limited by the observational nature of the included studies.

Reference: Staibano P, et al. Association of Tracheostomy With Outcomes in Patients With COVID-19 and SARS-CoV-2 Transmission Among Health Care Professionals: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. Published online May 27, 2021. doi:10.1001/jamaoto.2021.0930

2 Comments on "Enhanced PPE Associated With Low Rates of SARS-CoV-2 Transmission During Tracheostomy"

  1. 52649 699566great points altogether, you just gained a logo new reader. 441783

  2. 638199 985845Whilst you are any with the lucky enough choices, it comes evidently, while capture the fancy with the specific coveted by ly folks other helpful you you meet may possibly possibly nicely have hard times this certain problem. pre owned awnings 773505

Leave a comment

Your email address will not be published.